Skip to main content

Table 1 Anthropomorphic data at baseline for the patients with diabetes and Charcot foot (n = 163), distributed into a group that received long-term antibiotic treatment for foot infections during their Charcot foot treatment, and a group that did not receive antibiotics for this reason in the period (1996–2015)

From: Risk factors for development of nephropathy in patients with a diabetic Charcot foot

  Group with antibiotics (n = 105) Group without antibiotics (n = 58) P-value
Age (years) 55.4 ± 10.0 60.1 ± 9.1 0.004*
Sex (male/female)a 82/23 25/33 0.005*+
Diabetes type (I/II)a 30/75 10/48 0.109
Duration of diabetes (years)a 16.7 ± 12.4 16.6 ± 12.6 0.826
BMI (kg/m2)a 30.6 ± 9.3 29.1 ± 5.7 0.362
HbA1c (mmol/mol) 71 ± 22 65 ± 19 0.146
Systolic blood pressure (mmHg) 154 ± 22 145 ± 23 0.033*
Diastolic blood pressure (mmHg)a 83 ± 14 81 ± 15 0.393
P-creatinine (µmol/L)ab 93 ± 43 88 ± 29 0.947
U-albumine/creatinine ratio (mg)ac 113 ± 257 116 ± 214 0.717
  1. aNot normally distributed
  2. bReference level: 60–105 µmol/L for adult males, 45–90 µmol/L for adult females
  3. cReference level: < 30 mg normoalbuminuria, 30–299 mg microalbuminuria, > 300 mg macroalbuminuria
  4. *Significant at chosen α-level of 0.05
  5. +Significant difference in the distribution of male/female between the two groups